Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

U.S. NPWT Devices Market by Product (Conventional Stand-Alone Devices, Conventional Portable Devices, Disposable Devices), by Indication (Diabetes Foot Ulcers, Venous Leg Ulcers, Traumatic Wounds, Pressure Ulcers, Partial Thickness Burns, Others) and by End User (Ambulatory Settings Wound Care Centers, Home Healthcare Centers, Long Term Care Centers): Global Opportunity Analysis and Industry Forecast, 2023-2032

A00900

Pages: NA

Charts: NA

Tables: NA

Negative Pressure Wound Therapy (NPWT) devices are used to heal wounds by applying sub-atmospheric pressure using sealed dressing connected to vacuum pump. The vacuum source generates negative pressure to remove fluids, exudates, and infectious materials from wound and increases the flow of blood for healing purposes. These devices also help in healing first & second degree burns, acute wounds, and chronic wounds. NPWT devices allows flow of fluids, such as antibiotics and saline to wound. Awareness among people along with increase in confidence in NPWT physicians present new avenues for NPWT devices.

The driving factors of the U.S. NPWT devices market are increasing aging population, rise in prevalence of chronic diseases such as diabetes, cardiovascular disease, peripheral vascular disease, and increase in the incidence of cancer and neurological disease. However, high cost of procedure and unfavorable government policies are factors restraining the market growth. The advancement in technologies enable faster wound healing present opportunities for growth of the market.

The U.S. NPWT devices market is segmented based on products, indication, and end user. The product segment is classified further into conventional stand-alone devices, conventional portable devices, and disposable devices. Based on indications, the market is further classified into diabetes foot ulcers, venous leg ulcers, traumatic wounds, pressure ulcers, partial thickness burns, and others. The market is segmented based on end-user segment into ambulatory settings & wound care centers, home healthcare centers, and long term care centers.

The prominent market players are Smith & Nephew PLC, Invacare Corporation, Mlnlycke Health Care, Talley Group Ltd., ConvaTec, Inc., Devon Medical Inc., Genadyne Biotechnologies Inc., Innovative Therapies Inc., ATMOS MedizinTechnik GmbH Co. KG, and MediTop B.V. They have implemented strategies, such as expansion, partnerships, mergers, and others to sustain in the market.

KEY BENEFITS FOR STAKEHOLDERS:

  • The report offers a detailed analysis of key driving and hindering factors of the U.S. NPWT devices market.
  • This report offers an in-depth quantitative analysis of the current market and estimations through 2015 and 2020, which assists in identifying the prevailing market opportunities.
  • The report provides an extensive analysis of current and future market status of the U.S. NPWT devices market.
  • The report provides a comprehensive information about different active wound care products offered by prominent market players.
  • An extensive analysis of dominant market shares for each segment helps in understanding the current status of market.
  • The report provides an extensive information about new product launches, research and recent developments of the U.S. NPWT devices market.
  • An in-depth analysis of current research and clinical developments within the U.S. NPWT devices market is provided with key market dynamic factors that helps in understanding the behavior of the market.

KEY MARKET SEGMENTS:

  • By Product
    • Conventional Stand-Alone Devices
    • Conventional Portable Devices
    • Disposable Devices
  • By Indication
    • Diabetes Foot Ulcers
    • Venous Leg Ulcers
    • Traumatic Wounds
    • Pressure Ulcers
    • Partial Thickness Burns
    • Others
  • By End User
    • Ambulatory Settings & Wound Care Centers
    • Home Healthcare Centers
    • Long Term Care Centers

Key Market Player:

  • Smith & Nephew PLC
  • Invacare Corporation
  • Mlnlycke Health Care
  • Talley Group Ltd.
  • ConvaTec Inc.
  • Devon Medical Inc.
  • Genadyne Biotechnologies Inc.
  • Innovative Therapies Inc.
  • ATMOS MedizinTechnik GmbH Co. KG
  • MediTop B.V.

 

 

Key Market Segments

  • By Product
    • Conventional Stand-Alone Devices
    • Conventional Portable Devices
    • Disposable Devices
  • By Indication
    • Diabetes Foot Ulcers
    • Venous Leg Ulcers
    • Traumatic Wounds
    • Pressure Ulcers
    • Partial Thickness Burns
    • Others
  • By End User
    • Ambulatory Settings & Wound Care Centers
    • Home Healthcare Centers
    • Long Term Care Centers
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of LAMEA


Key Market Players

  • Smith & Nephew PLC
  • Invacare Corporation
  • Mlnlycke Health Care
  • Talley Group Ltd.
  • ATMOS MedizinTechnik GmbH Co. KG
  • Innovative Therapies Inc.
  • Devon Medical Inc.
  • Genadyne Biotechnologies Inc.
  • MediTop B.V.
  • ConvaTec Inc.
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: U.S. NPWT DEVICES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Conventional Stand-Alone Devices

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Conventional Portable Devices

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Disposable Devices

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: U.S. NPWT DEVICES MARKET, BY INDICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Indication

    • 5.2. Diabetes Foot Ulcers

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Venous Leg Ulcers

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Traumatic Wounds

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Pressure Ulcers

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Partial Thickness Burns

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Others

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: U.S. NPWT DEVICES MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Ambulatory Settings Wound Care Centers

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Home Healthcare Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Long Term Care Centers

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: U.S. NPWT DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Indication

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S.

        • 7.2.6.1 Market size and forecast, product

        • 7.2.6.2 Market size and forecast, indication

        • 7.2.6.3 Market size and forecast, end user

      • 7.2.7. Canada

        • 7.2.7.1 Market size and forecast, product

        • 7.2.7.2 Market size and forecast, indication

        • 7.2.7.3 Market size and forecast, end user

      • 7.2.8. Mexico

        • 7.2.8.1 Market size and forecast, product

        • 7.2.8.2 Market size and forecast, indication

        • 7.2.8.3 Market size and forecast, end user

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Indication

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France

        • 7.3.6.1 Market size and forecast, product

        • 7.3.6.2 Market size and forecast, indication

        • 7.3.6.3 Market size and forecast, end user

      • 7.3.7. Germany

        • 7.3.7.1 Market size and forecast, product

        • 7.3.7.2 Market size and forecast, indication

        • 7.3.7.3 Market size and forecast, end user

      • 7.3.8. Italy

        • 7.3.8.1 Market size and forecast, product

        • 7.3.8.2 Market size and forecast, indication

        • 7.3.8.3 Market size and forecast, end user

      • 7.3.9. Spain

        • 7.3.9.1 Market size and forecast, product

        • 7.3.9.2 Market size and forecast, indication

        • 7.3.9.3 Market size and forecast, end user

      • 7.3.10. UK

        • 7.3.10.1 Market size and forecast, product

        • 7.3.10.2 Market size and forecast, indication

        • 7.3.10.3 Market size and forecast, end user

      • 7.3.11. Russia

        • 7.3.11.1 Market size and forecast, product

        • 7.3.11.2 Market size and forecast, indication

        • 7.3.11.3 Market size and forecast, end user

      • 7.3.12. Rest Of Europe

        • 7.3.12.1 Market size and forecast, product

        • 7.3.12.2 Market size and forecast, indication

        • 7.3.12.3 Market size and forecast, end user

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Indication

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China

        • 7.4.6.1 Market size and forecast, product

        • 7.4.6.2 Market size and forecast, indication

        • 7.4.6.3 Market size and forecast, end user

      • 7.4.7. Japan

        • 7.4.7.1 Market size and forecast, product

        • 7.4.7.2 Market size and forecast, indication

        • 7.4.7.3 Market size and forecast, end user

      • 7.4.8. India

        • 7.4.8.1 Market size and forecast, product

        • 7.4.8.2 Market size and forecast, indication

        • 7.4.8.3 Market size and forecast, end user

      • 7.4.9. South Korea

        • 7.4.9.1 Market size and forecast, product

        • 7.4.9.2 Market size and forecast, indication

        • 7.4.9.3 Market size and forecast, end user

      • 7.4.10. Australia

        • 7.4.10.1 Market size and forecast, product

        • 7.4.10.2 Market size and forecast, indication

        • 7.4.10.3 Market size and forecast, end user

      • 7.4.11. Thailand

        • 7.4.11.1 Market size and forecast, product

        • 7.4.11.2 Market size and forecast, indication

        • 7.4.11.3 Market size and forecast, end user

      • 7.4.12. Malaysia

        • 7.4.12.1 Market size and forecast, product

        • 7.4.12.2 Market size and forecast, indication

        • 7.4.12.3 Market size and forecast, end user

      • 7.4.13. Indonesia

        • 7.4.13.1 Market size and forecast, product

        • 7.4.13.2 Market size and forecast, indication

        • 7.4.13.3 Market size and forecast, end user

      • 7.4.14. Rest of Asia Pacific

        • 7.4.14.1 Market size and forecast, product

        • 7.4.14.2 Market size and forecast, indication

        • 7.4.14.3 Market size and forecast, end user

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Indication

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil

        • 7.5.6.1 Market size and forecast, product

        • 7.5.6.2 Market size and forecast, indication

        • 7.5.6.3 Market size and forecast, end user

      • 7.5.7. South Africa

        • 7.5.7.1 Market size and forecast, product

        • 7.5.7.2 Market size and forecast, indication

        • 7.5.7.3 Market size and forecast, end user

      • 7.5.8. Saudi Arabia

        • 7.5.8.1 Market size and forecast, product

        • 7.5.8.2 Market size and forecast, indication

        • 7.5.8.3 Market size and forecast, end user

      • 7.5.9. UAE

        • 7.5.9.1 Market size and forecast, product

        • 7.5.9.2 Market size and forecast, indication

        • 7.5.9.3 Market size and forecast, end user

      • 7.5.10. Argentina

        • 7.5.10.1 Market size and forecast, product

        • 7.5.10.2 Market size and forecast, indication

        • 7.5.10.3 Market size and forecast, end user

      • 7.5.11. Rest of LAMEA

        • 7.5.11.1 Market size and forecast, product

        • 7.5.11.2 Market size and forecast, indication

        • 7.5.11.3 Market size and forecast, end user

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Smith And Nephew PLC

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Invacare Corporation

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Mlnlycke Health Care

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Talley Group Ltd.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. ConvaTec Inc.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Devon Medical Inc.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Genadyne Biotechnologies Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Innovative Therapies Inc.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. ATMOS MedizinTechnik GmbH Co. KG

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. MediTop B.V.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL U.S. NPWT DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. U.S. NPWT DEVICES MARKET FOR CONVENTIONAL STAND-ALONE DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. U.S. NPWT DEVICES MARKET FOR CONVENTIONAL PORTABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. U.S. NPWT DEVICES MARKET FOR DISPOSABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL U.S. NPWT DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 6. U.S. NPWT DEVICES MARKET FOR DIABETES FOOT ULCERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. U.S. NPWT DEVICES MARKET FOR VENOUS LEG ULCERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. U.S. NPWT DEVICES MARKET FOR TRAUMATIC WOUNDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. U.S. NPWT DEVICES MARKET FOR PRESSURE ULCERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. U.S. NPWT DEVICES MARKET FOR PARTIAL THICKNESS BURNS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. U.S. NPWT DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL U.S. NPWT DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 13. U.S. NPWT DEVICES MARKET FOR AMBULATORY SETTINGS WOUND CARE CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. U.S. NPWT DEVICES MARKET FOR HOME HEALTHCARE CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. U.S. NPWT DEVICES MARKET FOR LONG TERM CARE CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. U.S. NPWT DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA U.S. NPWT DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. U.S. U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. U.S. U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 23. U.S. U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. CANADA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. CANADA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 26. CANADA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE U.S. NPWT DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. GERMANY U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. ITALY U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. ITALY U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 42. ITALY U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. UK U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. UK U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 48. UK U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. RUSSIA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. RUSSIA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 51. RUSSIA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. REST OF EUROPE U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 54. REST OF EUROPE U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. ASIA-PACIFIC U.S. NPWT DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 59. CHINA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. CHINA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 61. CHINA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. JAPAN U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 64. JAPAN U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. INDIA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. INDIA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 67. INDIA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. AUSTRALIA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 73. AUSTRALIA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. THAILAND U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 76. THAILAND U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. MALAYSIA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 78. MALAYSIA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 79. MALAYSIA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. INDONESIA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. INDONESIA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 82. INDONESIA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. LAMEA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 87. LAMEA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. LAMEA U.S. NPWT DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 90. BRAZIL U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 91. BRAZIL U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 92. BRAZIL U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 93. SOUTH AFRICA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH AFRICA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. SAUDI ARABIA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. SAUDI ARABIA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 98. SAUDI ARABIA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 99. UAE U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 100. UAE U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 101. UAE U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 102. ARGENTINA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 103. ARGENTINA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 104. ARGENTINA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 105. REST OF LAMEA U.S. NPWT DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA U.S. NPWT DEVICES, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 107. REST OF LAMEA U.S. NPWT DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. SMITH AND NEPHEW PLC: KEY EXECUTIVES
  • TABLE 109. SMITH AND NEPHEW PLC: COMPANY SNAPSHOT
  • TABLE 110. SMITH AND NEPHEW PLC: OPERATING SEGMENTS
  • TABLE 111. SMITH AND NEPHEW PLC: PRODUCT PORTFOLIO
  • TABLE 112. SMITH AND NEPHEW PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. INVACARE CORPORATION: KEY EXECUTIVES
  • TABLE 114. INVACARE CORPORATION: COMPANY SNAPSHOT
  • TABLE 115. INVACARE CORPORATION: OPERATING SEGMENTS
  • TABLE 116. INVACARE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 117. INVACARE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. MLNLYCKE HEALTH CARE: KEY EXECUTIVES
  • TABLE 119. MLNLYCKE HEALTH CARE: COMPANY SNAPSHOT
  • TABLE 120. MLNLYCKE HEALTH CARE: OPERATING SEGMENTS
  • TABLE 121. MLNLYCKE HEALTH CARE: PRODUCT PORTFOLIO
  • TABLE 122. MLNLYCKE HEALTH CARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. TALLEY GROUP LTD.: KEY EXECUTIVES
  • TABLE 124. TALLEY GROUP LTD.: COMPANY SNAPSHOT
  • TABLE 125. TALLEY GROUP LTD.: OPERATING SEGMENTS
  • TABLE 126. TALLEY GROUP LTD.: PRODUCT PORTFOLIO
  • TABLE 127. TALLEY GROUP LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. CONVATEC INC.: KEY EXECUTIVES
  • TABLE 129. CONVATEC INC.: COMPANY SNAPSHOT
  • TABLE 130. CONVATEC INC.: OPERATING SEGMENTS
  • TABLE 131. CONVATEC INC.: PRODUCT PORTFOLIO
  • TABLE 132. CONVATEC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. DEVON MEDICAL INC.: KEY EXECUTIVES
  • TABLE 134. DEVON MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 135. DEVON MEDICAL INC.: OPERATING SEGMENTS
  • TABLE 136. DEVON MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 137. DEVON MEDICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. GENADYNE BIOTECHNOLOGIES INC.: KEY EXECUTIVES
  • TABLE 139. GENADYNE BIOTECHNOLOGIES INC.: COMPANY SNAPSHOT
  • TABLE 140. GENADYNE BIOTECHNOLOGIES INC.: OPERATING SEGMENTS
  • TABLE 141. GENADYNE BIOTECHNOLOGIES INC.: PRODUCT PORTFOLIO
  • TABLE 142. GENADYNE BIOTECHNOLOGIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. INNOVATIVE THERAPIES INC.: KEY EXECUTIVES
  • TABLE 144. INNOVATIVE THERAPIES INC.: COMPANY SNAPSHOT
  • TABLE 145. INNOVATIVE THERAPIES INC.: OPERATING SEGMENTS
  • TABLE 146. INNOVATIVE THERAPIES INC.: PRODUCT PORTFOLIO
  • TABLE 147. INNOVATIVE THERAPIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. ATMOS MEDIZINTECHNIK GMBH CO. KG: KEY EXECUTIVES
  • TABLE 149. ATMOS MEDIZINTECHNIK GMBH CO. KG: COMPANY SNAPSHOT
  • TABLE 150. ATMOS MEDIZINTECHNIK GMBH CO. KG: OPERATING SEGMENTS
  • TABLE 151. ATMOS MEDIZINTECHNIK GMBH CO. KG: PRODUCT PORTFOLIO
  • TABLE 152. ATMOS MEDIZINTECHNIK GMBH CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 153. MEDITOP B.V.: KEY EXECUTIVES
  • TABLE 154. MEDITOP B.V.: COMPANY SNAPSHOT
  • TABLE 155. MEDITOP B.V.: OPERATING SEGMENTS
  • TABLE 156. MEDITOP B.V.: PRODUCT PORTFOLIO
  • TABLE 157. MEDITOP B.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL U.S. NPWT DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL U.S. NPWT DEVICES MARKET
  • FIGURE 3. SEGMENTATION U.S. NPWT DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN U.S. NPWT DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALU.S. NPWT DEVICES MARKET
  • FIGURE 11. U.S. NPWT DEVICES MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 12. U.S. NPWT DEVICES MARKET FOR CONVENTIONAL STAND-ALONE DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. U.S. NPWT DEVICES MARKET FOR CONVENTIONAL PORTABLE DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. U.S. NPWT DEVICES MARKET FOR DISPOSABLE DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. U.S. NPWT DEVICES MARKET SEGMENTATION, BY INDICATION
  • FIGURE 16. U.S. NPWT DEVICES MARKET FOR DIABETES FOOT ULCERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. U.S. NPWT DEVICES MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. U.S. NPWT DEVICES MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. U.S. NPWT DEVICES MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. U.S. NPWT DEVICES MARKET FOR PARTIAL THICKNESS BURNS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. U.S. NPWT DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. U.S. NPWT DEVICES MARKET SEGMENTATION, BY END USER
  • FIGURE 23. U.S. NPWT DEVICES MARKET FOR AMBULATORY SETTINGS WOUND CARE CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. U.S. NPWT DEVICES MARKET FOR HOME HEALTHCARE CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. U.S. NPWT DEVICES MARKET FOR LONG TERM CARE CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: U.S. NPWT DEVICES MARKET
  • FIGURE 32. TOP PLAYER POSITIONING,2022
  • FIGURE 33. SMITH AND NEPHEW PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. SMITH AND NEPHEW PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. SMITH AND NEPHEW PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. INVACARE CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. INVACARE CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. INVACARE CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. MLNLYCKE HEALTH CARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. MLNLYCKE HEALTH CARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. MLNLYCKE HEALTH CARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. TALLEY GROUP LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. TALLEY GROUP LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. TALLEY GROUP LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. CONVATEC INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. CONVATEC INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. CONVATEC INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. DEVON MEDICAL INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. DEVON MEDICAL INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. DEVON MEDICAL INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. GENADYNE BIOTECHNOLOGIES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. GENADYNE BIOTECHNOLOGIES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. GENADYNE BIOTECHNOLOGIES INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. INNOVATIVE THERAPIES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. INNOVATIVE THERAPIES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. INNOVATIVE THERAPIES INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. ATMOS MEDIZINTECHNIK GMBH CO. KG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. ATMOS MEDIZINTECHNIK GMBH CO. KG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. ATMOS MEDIZINTECHNIK GMBH CO. KG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. MEDITOP B.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. MEDITOP B.V.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. MEDITOP B.V.: REVENUE SHARE, BY REGION, 2032 (%)

Purchase Full Report of
U.S. NPWT Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue